Abstract
Migraine in children and adolescents is a common condition. Emerging knowledge about the pathophysiology of migraine is leading to new targeted treatments toward specific mechanisms of migraine. This review explores the evidence for different treatments for pediatric migraine including the periodic syndromes of childhood that commonly represent precursors to migraine.
Similar content being viewed by others
References
Abu-Arefeh, I, Russel G. Prevalence of headache and migraine in schoolchildren. Brit Med J 1994; 309: 765–769.
Split W, Neuman W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache 1999; 39: 494–501.
Oleson J. The international classification of headache disorders. Cephalalgia 2004; 24: 1–160
Hershey AD, Winner P, Kabbouche MA, Gladstein J, Yonker M, Lewis D et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 2005; 45: 1288–1297.
Rossi LN, Vajani S, Cortinovis I, Spreafico F, Menegazzo L. Analysis of the International Classification of Headache Disorders for diagnosis of migraine and tension-type headache in children. Developmental Medicine and Child Neurology. 2008;50: 305–310
Winner P. Pediatric Headache. Current Opinion in Neurology 2008; 21:316–322.
Virtanen R, Aromaa M, Rautava P, Metsähonkala L, Anttila P, Helenius H et al. Changing headache from preschool age to puberty. Cephalalgia 2007; 27: 294–303.
Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2007; 13: 39–44.
Pietrobon, D, Striessnig J. Neurobiology of migraine. Nature Reviews 2003; 4: 386–398.
Silberstein S. Migraine. Lancet 2004;31: 381–391.
Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Annals of Neurology 2004; 55:19–26.
Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. New England 2001; 345: 17–24.
De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics 2003; 33: 192–196.
Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan J, Hoefnagels WA et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54: 360–366.
Kabbouche MA, Powers SW, Vockell AL, LeCates SL, Ellinor PL, Segers A et al. Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years. Headache 2005; 45: 1298–1303.
Damen L, Bruijn J, Koes BW, Berger MY, Passchier J, Verhagen AP. Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacologic trials. Cephalagia 2005; 26: 373–383.
Bruni O, Russo PM, Ferri R, Novelli L, Galli F, Guidetti V. Relationships between headache and sleep in a non-clinical population of children and adolescents. Sleep Medicine 2008; 9: 542–548.
Heng K, Wirrell E. Sleep disturbance in children with migraine. Child Neurology 2006; 21:761–766.
Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatric Annals 2005; 34: 449–460
Powers SW, Andrasik F. Biobehavioural treatment, disability and psychological effects of pediatric headache. Pediatric Annals 2005; 34: 461–465.
Powers SW, Hershey AD. Biofeedback for childhood migraine. In Maria BL, ed. Current Management in Child Neurology, 2nd ed. Hamilton, Ontario: BC Decker Inc; 2002; 83–85.
Eccleston C, Yorke L, Morley S, William AC de C, Mastroyannopoulou K. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Systems Review 2003; 1: 1–46
Kohen DP, Zajac R. Self-hypnosis training for headaches in children and adolescents. J Pediatr 2007; 150: 635–639.
Burstein R, Collin B. An association between migraine and cutaneous allodynia. Annals of Neurology 2000; 47: 614–624
Eidlitz-Markus T, Shuper A, Gorali O, Zeharia A. Migraine and cephalic cutaneous allodynia in pediatric patients. Headache 2007; 47: 1219–1223.
Lewis DW, Winner P, Wasiewski W. The placebo responder rate in children and adolescents. Headache 2005; 45: 232–239.
Fernandes R, Ferreira JJ, Sampaio C. The placebo response in studies of acute migraine. J Pediatr 2008; 152: 527–533.
Hamalainen ML, Hoppu K, Velkeila E Santavuori P. Ibuprofen or acetaminopen for the acute treatment of migraine in children: a double-blinded, randomized, placebo-controled crossover study. Neurology 1997; 48: 103–107.
Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toors, Northam RS, White LW, Lawson L. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002; 42: 780–786.
Lewis DW, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the AAN quality standards subcommittee and the Practice Committee of the Child Neurology Society 2004; 63: 2215–2224.
Dodick DW. Triptan nonresponder studies: Implications for clinical practice. Headache 2005; 45: 156–162.
Rapoport AM, Tepper SJ. Triptans are all different. Archives of Neurology 2001; 58: 1479–1480.
Dahlöf C. Infrequent or non-response to oral sumatriptan does not predict response to other triptans - review of four trials. Cephalalgia 2006; 26: 98–106.
Winner P, Rothner AD, Saper K et al. A randomized doubleblind, placebo controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106: 989–997.
Ahohen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology 2004; 62: 883–887.
Lewis DW, Winner P, Hershey AD, Wasiewski WW. Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120: 390–396.
Ahonen K, Hamalainen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 2006; 67: 1135–1140.
Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial. Headache 2008 (epub ahead of print)
Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ et al. Rapoport AM; MK-0974 Protocol 004 study group. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008; 70: 1304–1312.
Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 2007; 47: 1443–1446
Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 2006; 46: 57–63.
Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Annals of Emergency Medicine 2004; 43: 256–262.
Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 1985;5 Suppl 2:145–148.
Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988; 8: 1–6.
Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40: 539–549.
Lewis DW, Winner P. The Pharmacological Treatment Options for Pediatric Migraine: An Evidence-Based Appraisal. NeuroRx 2006; 3: 181–191.
Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004; 44: 230–237.
Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005; 45: 1304–1312.
Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebocontrolled trial. Child Neurology 2007; 22: 829–835.
Lewis DW, Paradiso E. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Headache 2007; 47: 1409–1417.
Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000; 40: 672–676.
Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M. Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Headache 2008; 48: 1012–1025.
Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine-an open-label study. Headache 2007; 47: 427–430.
Lindskog U, Odkvist L, Noaksson L, Wallquist J. Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache 1999; 39: 33–37.
Lewis DW. Headaches in Children and Adolescents. Current Problems in Pediatric and Adolescent Health Care 2007; 37: 207–246.
Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2006; 130: 1527–1537.
Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams J, Staiano A, Staiano A, Walker S. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006; 130:1527–1537.
Abu-Arafeh I, Russel G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Archives of Diseases of Childhood 1995; 72: 413–417.
Li BUK, Murray RD, Heitlinger LA, Robbins JL, Hayes JR. Is cyclic vomiting syndrome related to migraine? J Pediatr 1999; 134:567–572.
Li BUK, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder. Advances in Pediatrics 2000; 47: 117–160.
Al-Tawaijri WA, Shevell MI. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol 2002; 26: 365–368.
Fleisher DR. Cyclic Vomiting Syndrome: a paroxysmal disorder of brain -gut interaction. J Pediatr Gastroenterol and Nutr 1997; 25: 13S–15S.
Tarbell S, Li BU. Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents. Headache 2008; 48: 259–266.
Fitzpatrick E, Bourke B, Drumm B, Rowland M. Outcome for children with cyclic vomiting syndrome. Archives of Diseases of Childhood 2007; 92: 1001–1004.
Lindley K, Andrews P. Pathogenesis and Treatment of Cyclic Vomiting. J Pediatric Gastroenterol and Nutr 2005; 41: S38–S40.
Fleisher DR. Empiric guidelines for the management of cyclical vomiting syndrome. www.ch.missouri.edu/fleisher 2008.
Kothare SV. Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine. European J Pediatric Neurol 2005; 9: 23–26.
Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 1997; 100: 977–981.
Weydert JA, Ball TM, Davis MF. Systematic review of treatments for recurrent abdominal pain. Pediatrics 2003; 111: e11.
Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Archives of Disease in Childhood 1995; 72: 48–50.
Worawattanakul M, Rhoads JM, Lichtman SN, Ulshen MH. Abdominal migraine: prophylactic treatment and followup. J Pediatric Gastroenterol and Nutr 1999;28:37–40.
Boccia G, Del Giudice E, Crisanti AF, Strisciuglio C, Romano A, Staiano A. Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine. Cephalalgia 2006; 26: 1214–1219.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hung, R.M., MacGregor, D.L. Management of pediatric migraine: Current concepts and controversies. Indian J Pediatr 75, 1139–1148 (2008). https://doi.org/10.1007/S12098-008-0238-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/S12098-008-0238-8